BHF researchers secure EU approval for new AI heart attack prediction technology
Research funded by us has led to EU-approved artificial intelligence (AI) technology that can identify people at high risk of a fatal heart attack years before it strikes.
The first-of-its-kind technology, CaRi-Heart®, was developed by spinout company Caristo Diagnostics and has the power to detect ‘invisible’ risk in people with possible heart disease by using routine heart scans already performed in clinical practice. CaRi-Heart® has now received it’s CE mark accreditation, meaning it can be used by doctors across the UK and Europe, and can be rolled out across the NHS.
You can read the full article here.
AI awards help build evidence base for technologies – health secretary
In an exclusive column for Digital Health News, Secretary of State for Health and Social Care Steve Barclay says the…
THE BIOTECHNOLOGY BOOM IN OXFORD: A LOOK AT 15 EXCITING STARTUPS
Caristo Diagnostics Caristo Diagnostics is a startup that is using standard CT scans to identify potentially heart-stopping plaques. Their technology…